1. Market Research
  2. > Pharmaceutical Market Trends
Global Nanopharmaceutical Drugs Market: Focus on Nanodrugs and its Application in Therapeutics, Competitive Landscape, and Country - Analysis and Forecast (2018-2026)

Global Nanopharmaceutical Drugs Market: Focus on Nanodrugs and its Application in Therapeutics, Competitive Landscape, and Country - Analysis and Forecast (2018-2026)

  • November 2018
  • 267 pages
  • ID: 5644015
  • Format: PDF
  • BIS Research
Up to $1200 off Until Oct 31st 2020

Summary

Table of Contents

Global Nanopharmaceutical Drugs Market is Expected to Reach $79.29 billion by 2026

The pharmaceutical industry is focused on the most emerging branch in pharmaceutical sciences known as“ Pharmaceutical nanotechnology ”. The increasing prevalence of chronic diseases/disorder and development of the healthcare infrastructure are promoting the adoption of the novel medicine known as nanomedicine for better efficacy and improved patient outcome.

Nanomedicine works on same principle of nanotechnology, as the materials at nanoscale level possess unique characteristics as compared to macroscopic level.Nanomedicine has a multidisciplinary nature involving notions and techniques from biology, chemistry, and physics.

Nanotechnology provides exceptional benefits when applied to medical devices and pharmaceuticals.Furthermore, the patent cliff/expirations has the enabled the pharmaceutical companies to adopt new business strategies.

Many blockbuster drugs are going off-patent but the introduction of nanotechnology in medicines has revolutionized the pharmaceutical industry.With the advancement in the Nano pharmaceutical industry, the number of patent filings has dramatically increased.

Pharmaceutical companies have developed new strategies & techniques to re-patent drugs which are on the way to expiration by modifying them with the help of nanotechnology. Nanodrugs offers a promising potential in terms of revenue growth.

The purpose of this study is to gain a holistic view of the nanopharmaceutical drugs market in terms of various influencing factors such as recent trends, regulatory requirements, and technological advancements of the market.The scope of this report constitutes a detailed study of the drugs associated with the global nanopharmaceutical drugs market across different regions.

The market has been segmented into ‘drug carrier type,’ ‘application,’ ‘distribution channel,’ and ‘regions.’ The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering the market.

This research report aims at answering various aspects of the global nanopharmaceutical drugs market with the help of the key factors driving the market, restraints, and challenges that can inhibit the overall market growth and the current growth opportunities that are going to shape the future trajectory of the market expansion.The report includes an in-depth examination of the key players and recent developments taking place in this market.

Moreover, the report includes chapters on market dynamics (market drivers, opportunities, and challenges) and industry analysis as well.

The research study highlights the factors governing the industry attractiveness with Porter’s Five Forces for a comprehensive understanding of the global nanopharmaceutical drugs market. Moreover, the study includes detailed product mapping with further sub-segmentation in various countries, and in each sub-segment, the key market trends, list of the key companies, and the key strategies and developments have also been discussed.

The answers to the following key questions can be derived from this report:
• How did the Nanopharmaceutical Drugs market evolve, and what is its scope in the future?
• What are the major market drivers, challenges, and opportunities in the global Nanopharmaceutical Drugs market?
• What are the key developmental strategies that are implemented by the key players to sustain in this market?
• How will the influencing factors affect the industry attractiveness?
• How nanopharmaceutical Drugs is superior that conventional drugs?
• How will the investments by public and private companies and government organizations affect the global nanopharmaceutical drugs market?
• What was the market size of the leading segments and sub-segments of the global nanopharmaceutical drugs market in 2017?
• How will the industry evolve during the forecast period 2018-2026?
• What will be the growth rate of the nanopharmaceutical drugs during the forecast period?
• How will each segment of the global nanopharmaceutical drugs market grow during the forecast period, and what will be the revenue generated by each of the segments by the end of 2026?
• Which drug carrier segment, application segment and distribution channel is expected to register the highest CAGR for the nanopharmaceutical drugs market?
• What is the market size of nanopharmaceutical drugs in different countries of the world?
• Which geographical region will contribute to the highest sales of nanopharmaceutical drugs?
• Who are the key players in the nanopharmaceutical drugs market, and what are their contributions?

The key players who have been contributing significantly to the nanopharmaceutical drugs market include Pfizer, Inc, AstraZeneca, Gilead Sciences, and Astellas Pharma Inc., Abbvie Inc., Amgen, Merck & Co., Inc., Hoffmann-La Roche AG., Teva Pharmaceuticals Industries Limited, Novartis AG, CELGENE CORPORATION, Sanofi S.A., JOHNSON & JOHNSON, AMAG Pharmaceuticals and Shire plc., among others.

Executive Summary
Big pharma companies rely on blockbuster drugs for revenue generation.The patent protection allows the pharma company to sell the drugs at high profit margin, for example the Pfizer’s drug known as Lipitor, accounts for about $13 bn of Pfizer’s revenues.

Many blockbuster drugs are going off patent, drug manufacturers are facing challenges to develop novel research and development strategies, involving miniaturization through various techniques including nanotechnology.

The introduction of nanotechnology in medicines has revolutionized the pharmaceutical industry.With the advancement in the Nano pharmaceutical industry, the number of patent filings has dramatically increased.

Pharmaceutical companies have developed new strategies & techniques to re-patent drugs which are on the way to expiration by modifying them with the help of nanotechnology. Nanodrugs offers a promising potential in terms of revenue growth.

The nanopharmaceuticals have broach range of application and are used in imaging, diagnostics and therapeutics and possess full potential to dominate the pharmaceutical market. The introduction of nanomedicine will alter the landscape of medicine and will drastically improve a patient’s quality of life and reduce healthcare costs.

The purpose of this study is to gain a holistic view of the nanopharmaceutical drugs market in terms of various influencing factors, such as recent trends, regulatory requirements, and technological advancements of the market.The scope of this report constitutes a detailed study of the drugs associated with the global nanopharmaceutical drugs market across different regions.

The market has been segmented into ‘drug carrier type,’ ‘application,’ ‘distribution channel,’ and ‘regions.’ The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering the market. The global nanopharmaceutical drug market is valued $40.37 billion in 2017 and is expected to reach $79.29 billion by 2026.

The major factor driving the growth of this market, are government and private funding to support the development of regenerative medicine, rising prevalence of chronic diseases and genetic disorders, increase in global healthcare expenditure, and rapid growth in the aging population. Further, the increasing insurance coverage and reimburesement policies in the developed markets such as the U.S., Japan, Germany, and the U.K. are the key drivers for the growth of the nanopharmaceutical drugs market.

Moreover, among different therapeutic areas, the oncology therapeutic area dominated the global nanopharmaceutical drugs market in 2017.Nanoparticles offer an opportunity to introduce overall shift in cancer research.

Many drug candidates are under clinical investigation and have the potential to be introduced in the market.Ideal nanomedicines should follow the regulatory pathway of approval and should have a modular design that can be easily scaled up for cGMP manufacturing and stored for a long time prior to use in patients.

The Nanotechnology Characterization Laboratory and FDA works in collaboration to advance and review nanomedicine platform.

On the basis of regions, the global nanopharmaceutical drugs market is segmented into North America, Europe, Asia-Pacific, and Rest-of-the-World (RoW). North America is the leading contributor to the global nanopharmaceutical drugs market and contributed 51.78% in terms of revenue respectively to the global market in 2017. However, Europe and Asia-Pacific is expected to grow at a significant CAGR between 5% to 7% in terms of revenue respectively, during the forecast period.

The key players who have been contributing significantly to the nanopharmaceutical drugs market include Pfizer, Inc, AstraZeneca, Gilead Sciences, and Astellas Pharma Inc., Abbvie Inc., Amgen, Merck & Co., Inc., Hoffmann-La Roche AG., Teva Pharmaceuticals Industries Limited, Novartis AG, CELGENE CORPORATION, Sanofi S.A., JOHNSON & JOHNSON, AMAG Pharmaceuticals and Shire plc., among others.

Countries Covered
• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• The U.K.
• Spain
• Italy
• Rest-of-Europe
• Asia-Pacific
• China
• Japan
• Rest-of-Asia-Pacific
• Rest-of-the-World

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
15% Off

($5000)

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Real-World Evidence Solutions Market - Growth, Trends, and Forecasts (2020 - 2025)

  • $ 4250
  • September 2020
  • 125 pages

The real-world evidence solutions market will show rapid growth due to the shift from volume to value-based care, increasing aging population and prevalence of chronic diseases and delays in drug development ...

  • World
  • APAC
  • Healthcare
  • Pharmaceutical
  • Industry analysis
  • Cancer Incidence
  • Chronic Disease Prevalence

ref:plp2018

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on